Atlas Trials

Endoscopic Ultrasound Guided Radio Frequency Ablation of Pancreatic Neuroendocrine Neoplasms

Clinical trial NCT05243082 · RECRUITING

Trial details

NCT number
NCT05243082
Sponsor
Oslo University Hospital
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Pancreatic Neuroendocrine Tumors, WHO Grade I-II
Start date
2022-01-14
Primary completion
2025-01-14
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.